Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
EGFR receptor
Biotech
Janux's shares jump 130% following T-cell engager data drop
Janux Therapeutics’ executives aren’t the only ones celebrating positive interim phase 1 data from two tumor-focused candidates.
James Waldron
Feb 27, 2024 10:35am
Chronic pain pathway linked to lung cancer
Sep 1, 2022 9:15am
Hoth forges new alliance with Worldwide Clinical Trials
Apr 13, 2021 7:10am
A map of cell signaling networks could inspire new pain drugs
Mar 18, 2021 10:55am
J&J's bispecific curbs 74% of lung cancers with rare mutation
Jan 28, 2021 10:45pm
Takeda drug curbs 78% of lung cancers with rare EGFR mutation
Jan 28, 2021 8:00am